XCHC Reports On 'American Drug War 2' National Theatrical Release On June 6, 2013; TheStockRadio.com Interview With Kevin Booth
DALLAS, May 2, 2013 /PRNewswire/ -- The X-Change Corporation (NASDAQ OTC: XCHC), a U.S. boutique company whose niche is cannabinoid extract-based cosmeceutical and nutraceutical solutions through its Phytiva brand product line, is proud to be part of the strategic team for 'American Drug War 2'. TheStockRadio.com interviewed Mr. Booth about the film and its National Release on June 6, 2013.
The interview is available at http://thestockradio.com/director-kevin-booth-maker-of-american-drug-war-2/2629
A trailer for 'AMERICAN DRUG WAR 2' can be seen at http://www.youtube.com/user/AmericanDrugWar
Robert Kane, President of X-Change Corp., commented, "It is a privilege to be a part of some of the initial planning of the film and to have an appearance in the movie. The Cash Hyde story, which is shared in the American Drug War 2 film, is one that is important and should be shared. I encourage everyone interested in doing something positive in your community to go to www.tuggs.com and/or come out and support one of the events on June 6."About 'American Drug War 2' The film's distribution is being headed up by Gravitas Venture, a trend setting company that specializes in world-wide video-on-demand, as well as a theatrical release, through on-line start up TUGG.com. "Basically anyone - anywhere can go to TUGG.com and request a screening in his or her own area at a favorite theater. It's a new concept revolutionizing the industry called 'Theaters on Demand.' Once your theater has sold approximately 50 tickets – your event is booked. It's free and allows fans not only to participate but also to earn a little extra to give back to local legalization efforts. Simply go to http://www.tugg.com/titles/american-drug-war-2 and become one of our hosts," stated Kevin Booth, who hopes to blanket the country with the film on June 6, 2013. About TheStockRadio.com
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts